• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEW
    Legal
    Terms of usePrivacy policyCookie policy

    CEO Pickens Thomas Boone Iii was granted 50,000 shares, increasing direct ownership by 38% to 181,385 units (SEC Form 4)

    5/16/25 10:46:04 AM ET
    $ASTC
    Biotechnology: Laboratory Analytical Instruments
    Industrials
    Get the next $ASTC alert in real time by email
    SEC FORM 4 SEC Form 4
    FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

    Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
    or Section 30(h) of the Investment Company Act of 1940
    OMB APPROVAL
    OMB Number: 3235-0287
    Estimated average burden
    hours per response: 0.5
      
    Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
      
    Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
    1. Name and Address of Reporting Person*
    Pickens Thomas Boone III

    (Last) (First) (Middle)
    2105 DONLEY DR.
    SUITE 100

    (Street)
    AUSTIN TX 78758

    (City) (State) (Zip)
    2. Issuer Name and Ticker or Trading Symbol
    ASTROTECH Corp [ ASTC ]
    5. Relationship of Reporting Person(s) to Issuer
    (Check all applicable)
    X Director 10% Owner
    X Officer (give title below) Other (specify below)
    CEO
    3. Date of Earliest Transaction (Month/Day/Year)
    05/14/2025
    4. If Amendment, Date of Original Filed (Month/Day/Year)
    6. Individual or Joint/Group Filing (Check Applicable Line)
    X Form filed by One Reporting Person
    Form filed by More than One Reporting Person
    Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
    1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V Amount (A) or (D) Price
    Common Stock 05/14/2025(1) A 50,000 A $0 181,385 D
    Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
    (e.g., puts, calls, warrants, options, convertible securities)
    1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
    Explanation of Responses:
    1. Represents shares of restricted stock granted to the Reporting Person pursuant to the Astrotech Corporation 2021 Omnibus Equity Incentive Plan. The shares of restricted stock vest on each of the first three anniversaries of May 14, 2025, such that 100% of the shares of restricted stock granted shall be fully vested on May 14, 2028, subject to Reporting Person's continuous employment with the Issuer through each such applicable anniversary.
    /s/ Tom Pickens 05/16/2025
    ** Signature of Reporting Person Date
    Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
    * If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
    ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
    Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
    Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
    Get the next $ASTC alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ASTC

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $ASTC
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Amendment: SEC Form 4 filed by Chief Financial Officer Canas Jennifer

    4/A - ASTROTECH Corp (0001001907) (Issuer)

    6/5/25 4:42:15 PM ET
    $ASTC
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Chief Financial Officer Canas Jennifer was granted 5,250 shares (SEC Form 4)

    4 - ASTROTECH Corp (0001001907) (Issuer)

    6/4/25 5:05:17 PM ET
    $ASTC
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    SEC Form 3 filed by new insider Canas Jennifer

    3 - ASTROTECH Corp (0001001907) (Issuer)

    6/4/25 5:02:53 PM ET
    $ASTC
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    $ASTC
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Astrotech Corporation Appoints Nihanth Badugu as Chief Operating Officer

    AUSTIN, Texas, Aug. 18, 2025 (GLOBE NEWSWIRE) -- Astrotech Corporation (NASDAQ:ASTC) (the "Company" or "Astrotech"), today announced that it has appointed Nihanth Badugu as Chief Operating Officer ("COO") of the Company. Mr. Badugu's appointment is effective as of August 13, 2025. "The Board is thrilled to promote Mr. Badugu to Chief Operating Officer," stated Thomas B. Pickens III, Chairman and Chief Executive Officer of Astrotech Corporation. "Nihanth has been an invaluable asset to Astrotech since joining us in 2023. His dedication to operational excellence and program management has significantly advanced our objectives. We are confident in his ability to lead our operations as COO a

    8/18/25 4:45:00 PM ET
    $ASTC
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Astrotech Announces Deployment of EN-SCAN Devices to Transform Instant, On-Site Environmental Field Monitoring

    AUSTIN, Texas, Aug. 15, 2025 (GLOBE NEWSWIRE) -- -- Astrotech Corporation ("Astrotech" or the "Company") (NASDAQ:ASTC) announced today that it has introduced its new EN-SCAN product line ("EN-SCAN") of ultra-portable rugged environmental testing instruments, featuring its proprietary ATi Gas Chromatograph Column ("GC") and ATi Mass Spectrometer Technology™ ("MS") through its wholly owned subsidiary, EN-SCAN, Inc. By deploying EN-SCAN devices from Astrotech, customers gain access to real-time results and on-demand reporting, enabling continuous monitoring and immediate response in critical applications such as environmental compliance, refining, manufacturing, emergency response, and indu

    8/15/25 8:45:00 AM ET
    $ASTC
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Astrotech to Participate in the H.C. Wainwright 27th Annual Global Investment Conference in September 2025

    AUSTIN, Texas, Aug. 13, 2025 (GLOBE NEWSWIRE) -- Astrotech Corporation (NASDAQ:ASTC) (the "Company" or "Astrotech") today announced that Thomas B. Pickens III, Chairman and Chief Executive Officer, and Jennifer Cañas, Chief Financial Officer, will host investor meetings on Tuesday, September 9, 2025 as part of the H.C. Wainwright 27th Annual Global Investment Conference in New York City taking place at the Lotte New York Palace Hotel. Investors can register and request meetings with management via their HC Wainwright representative or Astrotech Investor Relations at [email protected]. About Astrotech Corporation Astrotech Corporation is a mass spectrometry company that creates, opera

    8/13/25 4:45:00 PM ET
    $ASTC
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    $ASTC
    SEC Filings

    View All

    Astrotech Corporation (DE) filed SEC Form 8-K: Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - ASTROTECH Corp (0001001907) (Filer)

    8/18/25 4:47:38 PM ET
    $ASTC
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Astrotech Corporation (DE) filed SEC Form 8-K: Leadership Update, Termination of a Material Definitive Agreement, Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - ASTROTECH Corp (0001001907) (Filer)

    5/28/25 5:26:26 PM ET
    $ASTC
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    SEC Form 10-Q filed by Astrotech Corporation (DE)

    10-Q - ASTROTECH Corp (0001001907) (Filer)

    5/14/25 9:20:19 AM ET
    $ASTC
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    $ASTC
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Becker James Frank bought $19,675 worth of shares (2,034 units at $9.67), increasing direct ownership by 14% to 16,121 units (SEC Form 4)

    4 - ASTROTECH Corp (0001001907) (Issuer)

    5/30/24 9:16:58 AM ET
    $ASTC
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Hinojosa Jaime bought $8,541 worth of shares (900 units at $9.49), increasing direct ownership by 13% to 7,881 units (SEC Form 4)

    4 - ASTROTECH Corp (0001001907) (Issuer)

    5/28/24 9:46:54 AM ET
    $ASTC
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Wilkinson Thomas Wiley bought $10,536 worth of shares (1,109 units at $9.50), increasing direct ownership by 6% to 20,862 units (SEC Form 4)

    4 - ASTROTECH Corp (0001001907) (Issuer)

    5/21/24 12:54:36 PM ET
    $ASTC
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    $ASTC
    Leadership Updates

    Live Leadership Updates

    View All

    Astrotech Corporation Appoints Nihanth Badugu as Chief Operating Officer

    AUSTIN, Texas, Aug. 18, 2025 (GLOBE NEWSWIRE) -- Astrotech Corporation (NASDAQ:ASTC) (the "Company" or "Astrotech"), today announced that it has appointed Nihanth Badugu as Chief Operating Officer ("COO") of the Company. Mr. Badugu's appointment is effective as of August 13, 2025. "The Board is thrilled to promote Mr. Badugu to Chief Operating Officer," stated Thomas B. Pickens III, Chairman and Chief Executive Officer of Astrotech Corporation. "Nihanth has been an invaluable asset to Astrotech since joining us in 2023. His dedication to operational excellence and program management has significantly advanced our objectives. We are confident in his ability to lead our operations as COO a

    8/18/25 4:45:00 PM ET
    $ASTC
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Astrotech Corporation Appoints Jennifer Cañas as Chief Financial Officer

    AUSTIN, Texas, May 28, 2025 (GLOBE NEWSWIRE) -- Astrotech Corporation (NASDAQ:ASTC) (the "Company" or ("Astrotech"), today announced that it has appointed Jennifer Cañas as Chief Financial Officer ("CFO") of the Company. Ms. Cañas' appointment is effective as of May 22, 2025. "The Board is delighted to promote Ms. Cañas to Chief Financial Officer," stated Thomas B. Pickens III, Chairman and Chief Executive Officer of Astrotech Corporation. "I have worked with Ms. Cañas since 2022 and have found her to be hard working, competent and knowledgeable. Management and the Board of Directors are excited to promote Jennifer to this position as she demonstrated strong leadership and delivered solid

    5/28/25 5:25:00 PM ET
    $ASTC
    $HTO
    Biotechnology: Laboratory Analytical Instruments
    Industrials
    Water Supply
    Utilities

    Jaime Hinojosa Resigns as Chief Financial Officer to Work in Family Business

    AUSTIN, Texas, Jan. 24, 2025 (GLOBE NEWSWIRE) -- Astrotech Corporation (NASDAQ:ASTC) ("Astrotech" or the "Company") announced the resignation of its Chief Financial Officer, Jaime Hinojosa, effective February 14, 2025.   Mr. Hinojosa will continue to serve in the CFO role until February 14, 2025, and after that time will provide transition services to the Company on a consulting basis through June 30, 2025. In connection with this development, the Company and its Board of Directors have appointed Ryan Polk to serve as interim Chief Financial Officer. "I will be moving to Houston to be closer to family and to work for our family business," said Mr. Hinojosa. "I am grateful to Tom Pickens,

    1/24/25 8:30:00 AM ET
    $ASTC
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    $ASTC
    Financials

    Live finance-specific insights

    View All

    Astrotech Announces Listing to the GSA as an Approved United States Government Vendor

    Astrotech Announces Listing to the GSA as an Approved United States Government Vendor AUSTIN, Texas, April 08, 2024 (GLOBE NEWSWIRE) -- Astrotech Corporation (NASDAQ:ASTC) ("Astrotech" or the "Company") and its wholly owned subsidiary, 1st Detect Corporation (1st Detect), announce that 1st Detect's TRACER 1000TM is now listed in the U.S. General Services Administration (GSA) IT Schedule 70 under Contract No. GS-35F-250GA with SRI Group LLC, Special Item Number 334290.   IT Schedule 70 is a long-term contract issued by the GSA to commercial technology vendors that allows sales to the U. S. federal government, one of the largest buyers of goods and services in the world. GSA's thoro

    4/8/24 9:00:00 AM ET
    $ASTC
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Astrotech to Showcase the Tracer 1000 Trace Detector at ISC West Conference

    AUSTIN, Texas, April 02, 2024 (GLOBE NEWSWIRE) -- Astrotech Corporation (NASDAQ:ASTC) ("Astrotech" or the "Company") and its wholly owned subsidiary, 1st Detect Corporation, announces that it will be showcasing its TRACER 1000 Narcotics Trace Detector ("NTD") and Explosives Trace Detector ("ETD") at the International Security Conference and Exposition, also known as ISC West, in Las Vegas, Nevada, from April 9-12, 2024, in booth number 2067. The TRACER 1000 is a high-performance laboratory instrument that is powered by the Astrotech Mass Spectrometer Technology™ ("AMS Technology"). Our mass spectrometer is capable of rapid detection of trace levels of narcotic or explosive compounds in

    4/2/24 9:00:00 AM ET
    $ASTC
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Astrotech Introduces the "Gold Standard" of Mass Spectrometry into Narcotics Detection Market with its State-of-the-Art Tracer 1000

     AUSTIN, Texas, March 25, 2024 (GLOBE NEWSWIRE) -- Astrotech Corporation (NASDAQ:ASTC) ("Astrotech" or the "Company") and its wholly owned subsidiary, 1st Detect Corporation, announces that it is currently accepting orders for the Tracer 1000 Narcotics Trace Detector (NTD). The TRACER 1000 NTD is a high-performance laboratory instrument capable of rapid detection of trace levels of narcotic compounds in seconds. Currently, the Company's Tracer 1000 Explosive Trace Detector (ETD) is now found in multiple locations in 14 countries throughout the world. The NTD provides a ruggedized platform that can be applied across various markets including airports, border security, checkpoint, cargo,

    3/25/24 9:00:00 AM ET
    $ASTC
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    $ASTC
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13D filed by Astrotech Corporation (DE)

    SC 13D - ASTROTECH Corp (0001001907) (Subject)

    6/26/23 4:00:53 PM ET
    $ASTC
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    SEC Form SC 13G/A filed by Astrotech Corporation (DE) (Amendment)

    SC 13G/A - ASTROTECH Corp (0001001907) (Subject)

    2/8/23 5:29:16 PM ET
    $ASTC
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    SEC Form SC 13G/A filed by Astrotech Corporation (DE) (Amendment)

    SC 13G/A - ASTROTECH Corp (0001001907) (Subject)

    2/8/23 4:02:50 PM ET
    $ASTC
    Biotechnology: Laboratory Analytical Instruments
    Industrials